T 0565/15 (MYCOPHENOLATE SODIUM SALT/Novartis AG, Novartis Pharma GmbH) of 02.02.2017
- European Case Law Identifier
- ECLI:EP:BA:2017:T056515.20170202
- Date of decision
- 2 February 2017
- Case number
- T 0565/15
- Petition for review of
- -
- Application number
- 04703158.8
- IPC class
- A61K 9/14
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- PROCESS FOR MODIFYING DRUG CRYSTAL FORMATION OF MYCOPHENOLATE SODIUM SALT
- Applicant name
- Novartis AG
Novartis Pharma GmbH - Opponent name
- Teva Pharmaceutical Industries Ltd.
Accord Healthcare Ltd - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(b)European Patent Convention Art 100(c)European Patent Convention Art 111(1)
- Keywords
- Amendments - Main request and auxiliary request 1 (No)
Amendments - Auxiliary request 2 (Yes)
Sufficiency of disclosure - Auxiliary request 2 (Yes) - Catchword
- -
- Cited cases
- G 0009/91
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division for further prosecution on the basis of the set of claims filed as auxiliary request 2 with letter of 6 October 2014.